Neurocrine Biosciences Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 143.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.29 | 52 Week High | $58.46 | |||
| Open | $143.29 | 52 Week Low | $31.25 | |||
| Day High | $143.29 | P/E | N/A | |||
| Day Low | $143.29 | EPS | $-0.69 | |||
| Volume | 2,417 | |||||
